Therapeutic efficacy of Traditional Vein Chemotherapy and Bronchial Arterial Infusion Combining with CIKs on Ⅲ Stage Non-small Cell Lung Cancer
Background and objective The therapeutic efficacy of late lung-cancer was very poor, and cytokine-induced killer cells (CIK) were paid more attention to treat non-small cell lung cancer (NSCLC). The aim of this study is to get insight into the role of bronchial arterial infusion bronchial arterial i...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2009-09-01
|
| Series: | Chinese Journal of Lung Cancer |
| Subjects: | |
| Online Access: | http://www.lungca.org/index.php?journal=01&page=article&op=viewFile&path[]=10.3779%2Fj.issn.1009-3419.2009.09.011&path[]=1103 |
| _version_ | 1828838201607847936 |
|---|---|
| author | Guangqiang ZHAO Yunchao HUANG Lianhua YE Lincan DUAN Yongchun ZHOU Kaiyun YANG Qianli MA Yujie LEI Xin SONG Ming HUANG Yinshan YANG |
| author_facet | Guangqiang ZHAO Yunchao HUANG Lianhua YE Lincan DUAN Yongchun ZHOU Kaiyun YANG Qianli MA Yujie LEI Xin SONG Ming HUANG Yinshan YANG |
| author_sort | Guangqiang ZHAO |
| collection | DOAJ |
| description | Background and objective The therapeutic efficacy of late lung-cancer was very poor, and cytokine-induced killer cells (CIK) were paid more attention to treat non-small cell lung cancer (NSCLC). The aim of this study is to get insight into the role of bronchial arterial infusion bronchial arterial infusion (BAI) plus CIK about NSCLC by comparing therapeutic efficacy among BAI, traditional vein chemotherapy and BAI plus CIK, for late NSCLC. Methods A total of 120 patients were enrolled in this study, dividing randomly into three groups: bronchial arterial infusion (BAI), traditional vein chemotherapy and BAI plus CIK. Clinical effects and side effects were estimated after two period of therapy. Results The effective rate (CR+PR%) of combined group is higher than the traditional vein chemotherapy group (66.67%, n=39) and there are significant differences (χ2=4.721, P=0.03); The side effect of rate of BAI plus CIK group is significantly lower than the traditional vein chemotherapy group, and so did the non-bone marrow inhibition side effects (P < 0.05). The tumor progression rate (PD%) of bronchial arterial infusion (BAI) group is higher than combined group (χ2=4.287, P=0.038). There was no difference between the traditional vein chemotherapy group and combined group (χ2=0.082, P=0.775). Conclusion Bronchial Artery Infusion combined with cytokine-induced killer cells is an ideal, safety, effective comprehensive treatment method for late stage lung cancer. |
| first_indexed | 2024-12-12T18:57:38Z |
| format | Article |
| id | doaj.art-5b56d382a4b84275a7f4bf96bee5176b |
| institution | Directory Open Access Journal |
| issn | 1009-3419 1999-6187 |
| language | zho |
| last_indexed | 2024-12-12T18:57:38Z |
| publishDate | 2009-09-01 |
| publisher | Chinese Anti-Cancer Association; Chinese Antituberculosis Association |
| record_format | Article |
| series | Chinese Journal of Lung Cancer |
| spelling | doaj.art-5b56d382a4b84275a7f4bf96bee5176b2022-12-22T00:15:12ZzhoChinese Anti-Cancer Association; Chinese Antituberculosis AssociationChinese Journal of Lung Cancer1009-34191999-61872009-09-0112910001004Therapeutic efficacy of Traditional Vein Chemotherapy and Bronchial Arterial Infusion Combining with CIKs on Ⅲ Stage Non-small Cell Lung CancerGuangqiang ZHAOYunchao HUANGLianhua YELincan DUANYongchun ZHOUKaiyun YANGQianli MAYujie LEIXin SONGMing HUANGYinshan YANGBackground and objective The therapeutic efficacy of late lung-cancer was very poor, and cytokine-induced killer cells (CIK) were paid more attention to treat non-small cell lung cancer (NSCLC). The aim of this study is to get insight into the role of bronchial arterial infusion bronchial arterial infusion (BAI) plus CIK about NSCLC by comparing therapeutic efficacy among BAI, traditional vein chemotherapy and BAI plus CIK, for late NSCLC. Methods A total of 120 patients were enrolled in this study, dividing randomly into three groups: bronchial arterial infusion (BAI), traditional vein chemotherapy and BAI plus CIK. Clinical effects and side effects were estimated after two period of therapy. Results The effective rate (CR+PR%) of combined group is higher than the traditional vein chemotherapy group (66.67%, n=39) and there are significant differences (χ2=4.721, P=0.03); The side effect of rate of BAI plus CIK group is significantly lower than the traditional vein chemotherapy group, and so did the non-bone marrow inhibition side effects (P < 0.05). The tumor progression rate (PD%) of bronchial arterial infusion (BAI) group is higher than combined group (χ2=4.287, P=0.038). There was no difference between the traditional vein chemotherapy group and combined group (χ2=0.082, P=0.775). Conclusion Bronchial Artery Infusion combined with cytokine-induced killer cells is an ideal, safety, effective comprehensive treatment method for late stage lung cancer.http://www.lungca.org/index.php?journal=01&page=article&op=viewFile&path[]=10.3779%2Fj.issn.1009-3419.2009.09.011&path[]=1103Lung neoplasmsBronchial arterial infusionCytokine-induced killer cellsChemotherapy |
| spellingShingle | Guangqiang ZHAO Yunchao HUANG Lianhua YE Lincan DUAN Yongchun ZHOU Kaiyun YANG Qianli MA Yujie LEI Xin SONG Ming HUANG Yinshan YANG Therapeutic efficacy of Traditional Vein Chemotherapy and Bronchial Arterial Infusion Combining with CIKs on Ⅲ Stage Non-small Cell Lung Cancer Chinese Journal of Lung Cancer Lung neoplasms Bronchial arterial infusion Cytokine-induced killer cells Chemotherapy |
| title | Therapeutic efficacy of Traditional Vein Chemotherapy and Bronchial Arterial Infusion Combining with CIKs on Ⅲ Stage Non-small Cell Lung Cancer |
| title_full | Therapeutic efficacy of Traditional Vein Chemotherapy and Bronchial Arterial Infusion Combining with CIKs on Ⅲ Stage Non-small Cell Lung Cancer |
| title_fullStr | Therapeutic efficacy of Traditional Vein Chemotherapy and Bronchial Arterial Infusion Combining with CIKs on Ⅲ Stage Non-small Cell Lung Cancer |
| title_full_unstemmed | Therapeutic efficacy of Traditional Vein Chemotherapy and Bronchial Arterial Infusion Combining with CIKs on Ⅲ Stage Non-small Cell Lung Cancer |
| title_short | Therapeutic efficacy of Traditional Vein Chemotherapy and Bronchial Arterial Infusion Combining with CIKs on Ⅲ Stage Non-small Cell Lung Cancer |
| title_sort | therapeutic efficacy of traditional vein chemotherapy and bronchial arterial infusion combining with ciks on iii stage non small cell lung cancer |
| topic | Lung neoplasms Bronchial arterial infusion Cytokine-induced killer cells Chemotherapy |
| url | http://www.lungca.org/index.php?journal=01&page=article&op=viewFile&path[]=10.3779%2Fj.issn.1009-3419.2009.09.011&path[]=1103 |
| work_keys_str_mv | AT guangqiangzhao therapeuticefficacyoftraditionalveinchemotherapyandbronchialarterialinfusioncombiningwithciksoniiistagenonsmallcelllungcancer AT yunchaohuang therapeuticefficacyoftraditionalveinchemotherapyandbronchialarterialinfusioncombiningwithciksoniiistagenonsmallcelllungcancer AT lianhuaye therapeuticefficacyoftraditionalveinchemotherapyandbronchialarterialinfusioncombiningwithciksoniiistagenonsmallcelllungcancer AT lincanduan therapeuticefficacyoftraditionalveinchemotherapyandbronchialarterialinfusioncombiningwithciksoniiistagenonsmallcelllungcancer AT yongchunzhou therapeuticefficacyoftraditionalveinchemotherapyandbronchialarterialinfusioncombiningwithciksoniiistagenonsmallcelllungcancer AT kaiyunyang therapeuticefficacyoftraditionalveinchemotherapyandbronchialarterialinfusioncombiningwithciksoniiistagenonsmallcelllungcancer AT qianlima therapeuticefficacyoftraditionalveinchemotherapyandbronchialarterialinfusioncombiningwithciksoniiistagenonsmallcelllungcancer AT yujielei therapeuticefficacyoftraditionalveinchemotherapyandbronchialarterialinfusioncombiningwithciksoniiistagenonsmallcelllungcancer AT xinsong therapeuticefficacyoftraditionalveinchemotherapyandbronchialarterialinfusioncombiningwithciksoniiistagenonsmallcelllungcancer AT minghuang therapeuticefficacyoftraditionalveinchemotherapyandbronchialarterialinfusioncombiningwithciksoniiistagenonsmallcelllungcancer AT yinshanyang therapeuticefficacyoftraditionalveinchemotherapyandbronchialarterialinfusioncombiningwithciksoniiistagenonsmallcelllungcancer |